Benlysta belimumab regulatory update

FDA's Arthritis Advisory Committee will meet on Nov. 16 to discuss a BLA from Human Genome Sciences for Benlysta belimumab to treat systemic lupus erythematosus (SLE). The human anti- BLyS (B lymphocy...